Sitemap
Pages
Posts by category
- Category: Board of Directors
- Category: News
- Cellular Architects at Work: Cells Building their Own Microgel Houses
- A Novel Microporous Biomaterial Vaccine Platform for Long-Lasting Antibody Mediated Immunity Against Viral Infection
- Pruett – Nature Regenerative Medicine 2023
- Accelerated wound healing by injectable microporous gel scafolds assembled from annealed building blocks
- Injection of Microporous Annealing Particle (MAP) Hydrogels in the Stroke Cavity Reduces Gliosis and Inflammation and Promotes NPC Migration to the Lesion
- Injectable Drug-Releasing Microporous Annealed Particle Scaffolds for Treating Myocardial Infarction
- Activating an adaptive immune response from a hydrogel scaffold imparts regenerative wound healing
- Category: Press
- Tempo Therapeutics Awarded $2.25 Million NIH SBIR Grant to Advance MAP™ Technology for Complex Wound Healing
- Tempo Therapeutics Closes Oversubscribed $14.5 Million Financing to Advance MAP(TM) Regenerative Technology
- Tempo Therapeutics selected into MedTech Innovator’s highly competitive 2025 Accelerator Cohort
- Tempo Therapeutics Announces First Patient Dosed in Clinical Trial of TT101 For Tissue Repair in Skin Cancer Surgery
- Tempo Therapeutics Announces Appointment of Eric I. Richman to Board of Directors
- Tempo Therapeutics Secures Series A Financing to Advance Cutting-Edge Tissue Scaffold Products into Clinical Trials
- Category: Tempo Advisors
- Category: The Tempo Team
Members
- Dino Di Carlo, PhD
- Robert Scott Kirsner, MD, PhD
- Steven Sands
- Eric Richman, MBA
- Eric Richman, MBA
- Westbrook Weaver, PhD
- Donald Griffin, PhD
- Biren Mehta
- Erik Oros
- Tatiana Segura, PhD
- Westbrook Weaver, PhD
- Donald Griffin, PhD
- Stephanie Deshayes, PhD
- Philip Scumpia, MD, PhD